Medicine News and Research

RSS

Immune reaction to dystrophin may contribute to muscle disease: Study

An immune reaction to dystrophin, the muscle protein that is defective in patients with Duchenne muscular dystrophy, may pose a new challenge to strengthening muscles of patients with this disease, suggests a new study appearing in the October 7, 2010, issue of The New England Journal of Medicine.

7 Oct 2010

Gymnemic acid nanocrystals could help develop soluble drug compounds

Researchers in India have demonstrated that producing nanoscopic crystals of a pharmaceutical product can allow the medication to be absorbed by the gut even if the drug is not soluble in water.

7 Oct 2010

Raloxifene drug may be useful in treating kidney disease in women: Study

The osteoporosis drug raloxifene may be useful in treating kidney disease in women, suggests a new study led by Michal Melamed, M.D., M.H.S., assistant professor of medicine and epidemiology & population health at the Albert Einstein College of Medicine of Yeshiva University.

7 Oct 2010

Vitamin D deficiency may impact orthopaedic procedure outcomes

Forty-three percent of patients scheduled to undergo orthopaedic surgery have insufficient levels of vitamin D and two out of five of those patients had levels low enough to place them at risk for metabolic bone disease, according to a study published this month in the October 6th issue of the Journal of Bone and Joint Surgery (JBJS).

7 Oct 2010

American Cancer Society awards 94 national research, training grants to 70 institutions nationwide

The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 94 national research and training grants totaling $46,633,000 to 70 institutions nationwide in the first of two grants cycles for 2011.

7 Oct 2010

Cincinnati Children's Hospital receives $12 million grant to create IBD registry

Building on the success of previous efforts among researchers and caregivers to improve the care of chronically ill children, a $12-million grant to Cincinnati Children's Hospital Medical Center will allow creation of a registry system unlike any before it, providing information in real time on thousands of cases around the country – and eventually the world.

7 Oct 2010

Top experts to discuss concussion-related issues at Ice Hockey summit

On Oct. 19-20, 2010, Mayo Clinic's Sports Medicine Center will host "Ice Hockey Summit: Action on Concussion." The summit will bring together top scientists, trainers, coaches, officials and manufacturers from across the United States, Canada and Europe to discuss concussion-related issues, including the science of concussions, impact on children, and sporting world response.

7 Oct 2010

Scientists develop first screening method to identify river blindness disease

Scientists from The Scripps Research Institute have developed the first screening method that rapidly identifies individuals with active river blindness, a parasitic disease that afflicts an estimated 37 million people. The test could change the current strategy of mass treatment in areas where river blindness, also known as onchocerciasis, is suspected.

7 Oct 2010

BioNJ creates special diagnostics committee to focus on personalized medicine

The strength of New Jersey's life sciences community and its unique ability to contribute to one of medicine's fastest growing areas—personalized medicine—has prompted BioNJ, the voice of the biotechnology industry in New Jersey, to create a special Diagnostics Committee.

7 Oct 2010

NIH grants $3.7 million to develop more accurate algorithms for tracking fetal development

Fetal growth is used as a marker of health and well-being in unborn babies as well as children. But, the tools that are currently available to differentiate between a small, healthy fetus and a fetus that is small due to pathologic causes have significant limitations. What if they were improved. Would it save the health care system resources spent monitoring women who might need medical intervention because their fetuses might just be small and healthy. Would it help some women avoid the anxiety such intervention brings.

7 Oct 2010

Herbal supplements can treat anxiety disorders

A systematic review of research into the use of nutritional supplements for the treatment of anxiety disorders has found strong evidence for the use of extracts of passionflower or kava and combinations of L-lysine and L-arginine. Researchers writing in BioMed Central's open access Nutrition Journal pooled the results of 24 studies involving a total of more than 2000 participants, showing that some nutritional and herbal supplements can be effective, without the risk of serious side effects.

7 Oct 2010

Patients with muscular dystrophy mount immune response to dystophin protein prior to gene therapy: Study

A clinical trial designed to replace the genetic defect causing the most common form of muscular dystrophy has uncovered an unexpected aspect of the disease. The trial, based on therapy designed by scientists at the University of North Carolina at Chapel Hill School of Medicine, showed that some patients mount an immune response to the dystrophin protein even before they have received the gene therapy.

7 Oct 2010

Today's Opeds: Mini-meds, Ariz.'s anti-health mandate and are premium refunds a bad thing?

With each new disruption come loud claims some from insurance executives that the health overhaul is damaging American health care. But when you dig a little deeper, you often discover the same lesson that the McDonald's case provides the real problem was the status quo.

7 Oct 2010

Vitamin D supplementation in healthy kids pointless: Study

According to a Cochrane Systematic Review released on October 6th, yesterday vitamin D supplements when given to healthy children with normal vitamin D levels does not improve bone density at the hip, lumbar spine, forearm or in the body as a whole.

6 Oct 2010

Speed cameras reduce road accidents significantly: Study

Although many drivers dislike the idea of speed cameras, a study of international research showed on Wednesday that this kind of monitoring of roads does cut the number of traffic injuries and deaths.

6 Oct 2010

Odd foreign bodies removed from patients

Sermo, the world's largest online community for physicians, today announced its weekly hot topic. Of over 200 physician respondents to an online poll and discussion, 85% said they have removed odd foreign bodies from patients.

6 Oct 2010

Nautilus Neurosciences announces exclusive co-promotion agreement for CAMBIA drug

Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company, and Mission Pharmacal Company, a privately-held pharmaceutical company focused on the women's health market announced today their exclusive co-promotion agreement for CAMBIA (diclofenac potassium for oral solution) to obstetrician's, gynecologists and other women's health medical professionals.

6 Oct 2010

CASMED presents abstracts of FORE-SIGHT Absolute Oximeter technology at American Academy of Pediatrics

CAS Medical Systems, Inc. today announced that three scientific abstracts demonstrating the use of the Company's FORE-SIGHT Absolute Oximeter were presented at the annual conference of the American Academy of Pediatrics in San Francisco, CA, October 2-5, 2010.

6 Oct 2010

BIOTRONIK's EchoCRT clinical trial design published in European Heart Journal

BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac devices and sponsor of clinical research to advance patient care and evidence-based medicine, announced the publication in the September 23, 2010 issue of the European Heart Journal of a peer-reviewed article that describes the rationale for the echocardiographic methods and dyssynchrony cutoff values selected for the EchoCRT study.

6 Oct 2010

PDGF identified as key factor in proliferation and transformation of epicardial cells

In research that one day may lead to the discovery of how to regenerate tissue damaged by heart disease, investigators at Childrens Hospital Los Angeles have identified PDGF as a key factor in the proliferation and transformation of epicardial cells, one type of cell that surrounds heart muscle and contributes to vessels.

6 Oct 2010

Medicine News and Research

Immune reaction to dystrophin may contribute to muscle disease: Study

Gymnemic acid nanocrystals could help develop soluble drug compounds

Raloxifene drug may be useful in treating kidney disease in women: Study

Vitamin D deficiency may impact orthopaedic procedure outcomes

American Cancer Society awards 94 national research, training grants to 70 institutions nationwide

Cincinnati Children's Hospital receives $12 million grant to create IBD registry

Top experts to discuss concussion-related issues at Ice Hockey summit

Scientists develop first screening method to identify river blindness disease

BioNJ creates special diagnostics committee to focus on personalized medicine

NIH grants $3.7 million to develop more accurate algorithms for tracking fetal development

Herbal supplements can treat anxiety disorders

Patients with muscular dystrophy mount immune response to dystophin protein prior to gene therapy: Study

Today's Opeds: Mini-meds, Ariz.'s anti-health mandate and are premium refunds a bad thing?

Vitamin D supplementation in healthy kids pointless: Study

Speed cameras reduce road accidents significantly: Study

Odd foreign bodies removed from patients

Nautilus Neurosciences announces exclusive co-promotion agreement for CAMBIA drug

CASMED presents abstracts of FORE-SIGHT Absolute Oximeter technology at American Academy of Pediatrics

BIOTRONIK's EchoCRT clinical trial design published in European Heart Journal

PDGF identified as key factor in proliferation and transformation of epicardial cells

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News